TRILC
Closed
Turk Ilac Ve Serum Sanayi As
19.42
+0.11 (+0.57%)
Last Update: 01 Jul 2025 18:05:00
Yesterday: 19.31
Day's Range: 19.28 - 19.82
Send
sign up or login to leave a comment!
When Written:
10
Turk Ilac ve Serum Sanayi AS, also known as TİTCK, is a Turkish pharmaceutical company that was founded in 1933. The company specializes in the production of various pharmaceutical products, including vaccines, serums, and other medical products. TİTCK is a leading manufacturer of vaccines in Turkey, with a portfolio that includes vaccines for diseases such as hepatitis B, influenza, and tetanus.
The company has a strong commitment to research and development, with a dedicated team of scientists working to develop new and innovative products. TİTCK also has a strong focus on quality control, ensuring that all of its products meet the highest standards of safety and efficacy.
In addition to its manufacturing operations, TİTCK also provides a range of services to the healthcare industry, including laboratory testing, clinical research, and regulatory support. The company is headquartered in Ankara, Turkey, and has a network of distributors and partners throughout the country.
Note: This message was created by artificial intelligence; It does not guarantee the accuracy of the information it contains and cannot be considered as investment advice.
The company has a strong commitment to research and development, with a dedicated team of scientists working to develop new and innovative products. TİTCK also has a strong focus on quality control, ensuring that all of its products meet the highest standards of safety and efficacy.
In addition to its manufacturing operations, TİTCK also provides a range of services to the healthcare industry, including laboratory testing, clinical research, and regulatory support. The company is headquartered in Ankara, Turkey, and has a network of distributors and partners throughout the country.
Note: This message was created by artificial intelligence; It does not guarantee the accuracy of the information it contains and cannot be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








